Zacks Research Has Positive Forecast for TSE:BHC Q1 Earnings

Bausch Health Companies Inc. (TSE:BHC) – Equities researchers at Zacks Research lifted their Q1 2025 earnings per share estimates for shares of Bausch Health Companies in a research note issued to investors on Monday, January 20th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $1.25 for the quarter, up from their previous estimate of $1.22. The consensus estimate for Bausch Health Companies’ current full-year earnings is $5.55 per share. Zacks Research also issued estimates for Bausch Health Companies’ Q2 2025 earnings at $1.49 EPS, Q1 2026 earnings at $1.58 EPS, Q2 2026 earnings at $1.65 EPS and Q3 2026 earnings at $1.98 EPS.

Separately, Evercore ISI raised shares of Bausch Health Companies to a “hold” rating in a research report on Tuesday, October 15th.

Bausch Health Companies Price Performance

BHC opened at C$11.12 on Wednesday. The company has a 50 day moving average of C$11.24 and a two-hundred day moving average of C$10.33. Bausch Health Companies has a 52-week low of C$5.45 and a 52-week high of C$15.43. The company has a quick ratio of 0.58, a current ratio of 1.19 and a debt-to-equity ratio of 7,583.76. The company has a market cap of C$4.08 billion, a P/E ratio of -6.35, a P/E/G ratio of 0.21 and a beta of 0.77.

Bausch Health Companies (TSE:BHC) last issued its earnings results on Wednesday, October 30th. The company reported C$1.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of C$1.43 by C$0.10. The business had revenue of C$3.42 billion during the quarter, compared to analysts’ expectations of C$3.36 billion. Bausch Health Companies had a negative return on equity of 2,304.54% and a negative net margin of 5.12%.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.